IntegraGen SA engages in the development of genetic biomarkers. It also develops and markets molecular diagnostic products and services in the fields of autism and oncology. The company was founded by Jörg Hager on June 26, 2000 and is headquartered in Evry, France.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company